Skip to main content

surgery of damaged cartilage (Chondroplasty) Clinical Review and Trends

Chondroplasty is a surgery of damaged cartilage with an aim to reduce friction in joints such as knee joint. In healthy condition articular cartilage which covers the end of the bones that form the joint is smooth and provides low friction surface for the joint structures.

However, in conditions such as arthritis, trauma, injuries etc. it becomes rough and damaged causing pain and swelling. Joint cartilage once damaged naturally heals poorly in most cases. Chondroplasty is performed to decrease complications, risks, and recovery time. The purpose of chondroplasty is to remove away the damaged joint surface.

Key players profiled in the report are –
  • Braun Melsungen AG
  • NuOrtho Surgical Inc.
  • Zimmer Biomet Holdings Inc.
  • Smith & Nephew plc
  • Nebula Inc.
  • Gpcmedical
  • Osiris Therapeutics Inc.
  • Sklar Surgical Instruments
  • Stryker Corporation and others.
Market Segmental Analysis:

The global Chondroplasty Industry has been segmented on the basis of types, anatomy, instruments and end users.

Based on types, the market has been segmented as radiofrequency ablation chondroplasty, abrasion chondroplasty, atellar chondroplasty, meniscal repair, tissue removal, and others.

Based on anatomy, the market has been segmented as knee, shoulder, hip, and others.

Based on instruments, the market has been segmented as shavers, RF devices, arthroscope and others.

Based on the end users, the market has been segmented as hospitals & orthopedic clinics, academic and research and others.


Regional Analysis:

The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new instruments and surgical techniques in the US drives the Chondroplasty Industry. The good reimbursement scenario and the greater awareness in the developed regions drive the market.

Europe is the second largest market in the world due to high income and healthcare penetration.
Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.

About Market Research Future: we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Comments

Popular posts from this blog

New Vascular Graft Market Techniques, Technology Enhancement and Industry Outlook 2020 to 2023

Vascular Graft Market Research by Raw Material (Polyester Grafts, EPTFE Grafts, Polyurethane Grafts, Biosynthetic Grafts), Indication (Endovascular Aneurysm Repair, Peripheral Vascular Repair, Hemodialysis Access), End-user (Hospitals, Ambulatory Surgical Centers), and Region-Global Forecast till 2023 Global  Vascular Graft Market   In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue Major Key Players The key strategies followed by the players operating in the global Vascular Graft Market were innovation, product development, acquisition, and expansion. Cardinal Health (US), Gore Medical (US), Terumo (Japan), C. R. Bard (US), Medtronic (Ireland), LeMaitre Vascular (US), B. Braun Melsugen AG (Germany), Endologix (US), Maquet (Germany), and Cook Medical (US).    Market Segment Analysis Global Vascu

Vascular Closure Devices Market Key Company Profile, Global Industry Trends and Future Development Aspects

Vascular Closure Devices Market Research Report, by Product Type (Passive Vascular Closure Device, Active Vascular Closure Device, External Hemostatic Device), Access (Femoral, Radial), Procedures (Interventional Cardiology, Interventional Radiology), Application (Diagnostic, Therapeutic), End User (Hospitals & Clinics, ASCs) – Global Forecast Till 2023 The  Vascular Closure Devices Market  In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue. Major Key Players The key strategies followed by the players operating in the global Vascular Closure Devices Market were innovation, product development, acquisition, and expansion. Abbott Laboratories, Terumo Corporation, Cardinal Health Inc., Cardiva Medical Inc., Morris Innovative, Inc., Medtronic plc, Essential Medical, Inc., Merit Medical Systems, Inc., TZ

Anophthalmia And Microphthalmia Market Growth Opportunities, Size, Technology Status and Outlook To 2023

The  “Global Anophthalmia And Microphthalmia Market can expect a CAGR of 5.8% during the forecast period”,  Reveals Market Research Future (MRFR). Anophthalmia and Microphthalmia Market Overview Anophthalmia and Microphthalmia are two physical deformities that directly impact the vision and can cause blindness. The associated medicinal procedures can assist the anophthalmia and microphthalmia market to grow in the coming years. Prevalence of genetic disorders and other abnormalities such as exposure to X-rays, chemicals, drugs, pesticides, toxins, radiation, or viruses, increase the risk of anophthalmia and microphthalmia. The detailed report includes genetic disorders, neurological abnormalities, and facial dysmorphisms as drivers that would have significant roles to play in the growth of the market. Request a Free Sample at  https://www.marketresearchfuture.com/sample_request/4724 According to the World Health Organization (WHO), an estimated 253 million people live with